Drugplain

ZOLADEX 3.6 mg/1

goserelin · IMPLANT · TerSera Therapeutics LLC

No Recall History
Plain English

ZOLADEX is a implant containing goserelin at 3.6 mg/1, taken subcutaneous. Manufactured by TerSera Therapeutics LLC.

Key Facts

Brand Name
ZOLADEX
Generic Name
goserelin
NDC Code (Product)
70720-950
Manufacturer
TerSera Therapeutics LLC
Strength
3.6 mg/1
Dosage Form
IMPLANT
Route
SUBCUTANEOUS
Marketing Status
Application #
NDA019726
Marketing Start
03/31/2018

Recall History

No Recall History

Frequently Asked Questions

What is ZOLADEX used for?

ZOLADEX contains goserelin. It is a implant taken subcutaneous. Consult your doctor for specific uses.

Is ZOLADEX a controlled substance?

ZOLADEX is not classified as a controlled substance by the DEA.

What is the generic name for ZOLADEX?

The generic name for ZOLADEX is goserelin. There are no other listed brand versions of goserelin.

What is the NDC code for ZOLADEX 3.6 mg/1?

The NDC (National Drug Code) for ZOLADEX 3.6 mg/1 is 70720-950, listed by TerSera Therapeutics LLC.

Product NDC

70720-950

Package NDC

70720-950-36

Other ZOLADEX Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)